Stage IB Breast Cancer Active Not Recruiting Phase 2 Trials for Telapristone acetate (DB05253)

IndicationStatusPhase
DBCOND0029218 (Stage IB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01800422Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast CancerTreatment
NCT02314156Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyPrevention